These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Filgrastim treatment of three patients with clozapine-induced agranulocytosis. Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786 [TBL] [Abstract][Full Text] [Related]
3. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS? Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor (GM-CSF) treatment of clozapine-induced agranulocytosis: a case report. Barnas C; Zwierzina H; Hummer M; Sperner-Unterweger B; Stern A; Fleischhacker WW J Clin Psychiatry; 1992 Jul; 53(7):245-7. PubMed ID: 1639744 [TBL] [Abstract][Full Text] [Related]
5. Clozapine-induced agranulocytosis: non-cross-reactivity with other psychotropic drugs. Lieberman JA; Johns CA; Kane JM; Rai K; Pisciotta AV; Saltz BL; Howard A J Clin Psychiatry; 1988 Jul; 49(7):271-7. PubMed ID: 3391979 [TBL] [Abstract][Full Text] [Related]
6. Clozapine treatment after agranulocytosis induced by classic neuroleptics. Bauer M; Mackert A J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676 [TBL] [Abstract][Full Text] [Related]
7. [A case study; ethnicity and clozapine, a risky combination?]. Laan WJ; Ramlal D Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282 [TBL] [Abstract][Full Text] [Related]
8. [Agranulocytosis caused by clozapine: the importance of leukocyte monitoring and efficacy of hematopoietic growth factors]. van Melick EJ; Touw DJ; Haak HL Ned Tijdschr Geneeskd; 1995 Nov; 139(47):2437-40. PubMed ID: 8524426 [TBL] [Abstract][Full Text] [Related]
10. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Schulte P Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571 [TBL] [Abstract][Full Text] [Related]
11. Haematological side effects of clozapine: patient characteristics. Miller PR; Cutten AE N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414 [TBL] [Abstract][Full Text] [Related]
12. [Hematologic effects of clozapine: evaluation of the international experience]. Lamarque V Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344 [TBL] [Abstract][Full Text] [Related]
13. White blood cell monitoring during long-term clozapine treatment. Cohen D; Monden M Am J Psychiatry; 2013 Apr; 170(4):366-9. PubMed ID: 23545791 [TBL] [Abstract][Full Text] [Related]
14. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats. Ip J; Uetrecht JP Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444 [TBL] [Abstract][Full Text] [Related]
15. Clozapine: the commitment to patient safety. Alphs LD; Anand R J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610 [TBL] [Abstract][Full Text] [Related]
16. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report. Tanríverdi N; Yazící KM Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523 [No Abstract] [Full Text] [Related]
17. High clozapine concentrations in leukocytes in a patient who developed leukocytopenia. Bergemann N; Abu-Tair F; Aderjan R; Kopitz J Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1068-71. PubMed ID: 17467133 [TBL] [Abstract][Full Text] [Related]